Prostate Cancer Trial, Recruiting (NCT04765150)

Prostate Cancer Trial, Recruiting NCT04765150 Sponsor: Jonsson Comprehensive Cancer Center Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04765150 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are male and aged 18 years or older
People who either have a clinical suspicion of prostate cancer or have had prostate cancer confirmed through a biopsy
People who have had or are currently having a specific type of prostate MRI scan (multi-parametric 3T MRI) at UCLA (University of California at Los Angeles)
People who are able to give their informed consent to take part

Who may not be able to join:

People who have medical reasons that make MRI scanning unsafe for them, such as having a heart device, prosthetic heart valves, or severe claustrophobia
People who have medical reasons that make it unsafe to receive gadolinium contrast dye (a substance sometimes used during MRI scans), not including the possibility of an allergic reaction to it (confirm with trial site)
People who have previously received radiotherapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kyung H Sung, PhD, UCLA / Jonsson Comprehensive Cancer Center

Phone: (310) 794-7952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04765150

Sponsor: Jonsson Comprehensive Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: (310) 794-7952

More information: https://clinicaltrials.gov/study/NCT04765150

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are male and aged 18 years or older
People who either have a clinical suspicion of prostate cancer or have had prostate cancer confirmed through a biopsy
People who have had or are currently having a specific type of prostate MRI scan (multi-parametric 3T MRI) at UCLA (University of California at Los Angeles)
People who are able to give their informed consent to take part

Who may not be able to join:

People who have medical reasons that make MRI scanning unsafe for them, such as having a heart device, prosthetic heart valves, or severe claustrophobia
People who have medical reasons that make it unsafe to receive gadolinium contrast dye (a substance sometimes used during MRI scans), not including the possibility of an allergic reaction to it (confirm with trial site)
People who have previously received radiotherapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jonsson Comprehensive Cancer Center

Registry

ClinicalTrials.gov

Start date

1 April 2021

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Development of quantitative dynamic contrast (DCE)-enhanced-magnetic resonance imaging (MRI) analysis techniques; Development of diffusion weighted imaging (DWI) methods that reduce prostate geometric distortion; Development of multi-class deep learning models

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov